| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +180,000 | 100% | $1.09 | +$196,731 |
| Sells | 0 | ||||
| Net | +2 | +180,000 | 100% | +$196,731 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sotirios Stergiopoulos | Director | $16,643,000 | 17 Sep 2021 | ||
| A2A Pharmaceuticals, Inc. | 10%+ Owner | $13,238,750 | 31 May 2023 | ||
| Bihua Chen | Former Director | $7,325,684 | 01 Aug 2025 | ||
| Rainer M. Erdtmann | Officer, Director | $2,290,795 | +$97,551 | +4.4% | 31 Dec 2025 |
| Franco Valle | Chief Financial Officer | $264,591 | 30 Nov 2024 | ||
| Michael J.m. Hitchcock | Interim CEO, Director | $114,057 | +$99,180 | +667% | 02 Dec 2025 |
| Juan Pablo Frias | Chief Medical Officer | $3,121 | 31 May 2024 | ||
| Thomas Andrew Butler | Chief Executive Officer, Director, 10%+ Owner | 17 Jan 2024 | |||
| Biomea Health, LLC | 10%+ Owner | 01 Jun 2022 | |||
| Eric Aguiar | Director | 11 Jun 2025 | |||
| Elizabeth Faust | Director | 11 Jun 2025 | |||
| Sumita Ray | Director | 11 Jun 2025 | |||
| Julianne Averill | Director | 22 Jul 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Rainer M. Erdtmann | BMEA | Common Stock | Gift | 250% | 50,000 | 70,000 | 31 Dec 2025 | By son | ||
| Rainer M. Erdtmann | BMEA | Common Stock | Gift | 100,600 | 70,000 | 31 Dec 2025 | By daughter | |||
| Rainer M. Erdtmann | BMEA | Common Stock | Gift | -20.8% | -150,600 | 572,427 | 31 Dec 2025 | Direct | ||
| Rainer M. Erdtmann | BMEA | Common Stock | Purchase | 4.33% | $42,999 | $1.43 | 30,000 | 723,027 | 11 Dec 2025 | Direct |
| Michael J.m. Hitchcock | BMEA | Common Stock | Purchase | 666.7% | $99,180 | $0.9918 | 100,000 | 115,000 | 02 Dec 2025 | Direct |
| Rainer M. Erdtmann | BMEA | Common Stock | Purchase | 1.46% | $10,500 | $1.05 | 10,000 | 693,027 | 01 Dec 2025 | Direct |
| Rainer M. Erdtmann | BMEA | Common Stock | Purchase | 6.22% | $44,052 | $1.10 | 40,000 | 683,027 | 28 Nov 2025 | Direct |
| Michael J.m. Hitchcock | BMEA | Stock Option (Right to Buy) | Award | 916,434 | 916,434 | 11 Aug 2025 | Direct | |||
| Rainer M. Erdtmann | BMEA | Stock Option (Right to Buy) | Award | 1,246,989 | 1,246,989 | 11 Aug 2025 | Direct | |||
| Julianne Averill | BMEA | Stock Option (Right to Buy) | Award | 241,177 | 241,177 | 22 Jul 2025 | Direct | |||
| Elizabeth Faust | BMEA | Stock Option (Right to Buy) | Award | 91,970 | 91,970 | 11 Jun 2025 | Direct | |||
| Eric Aguiar | BMEA | Stock Option (Right to Buy) | Award | 91,970 | 91,970 | 11 Jun 2025 | Direct | |||
| Sumita Ray | BMEA | Stock Option (Right to Buy) | Award | 91,970 | 91,970 | 11 Jun 2025 | Direct | |||
| Bihua Chen | BMEA | Stock Option (Right to Buy) | Award | 91,970 | 91,970 | 11 Jun 2025 | Direct | |||
| Michael J.m. Hitchcock | BMEA | Stock Option (Right to Buy) | Award | 350,000 | 350,000 | 26 Mar 2025 | Direct |